FNWFX
Price
$82.52
Change
-$0.32 (-0.39%)
Updated
Dec 17 closing price
TEQKX
Price
$10.96
Change
-$0.10 (-0.90%)
Updated
Dec 17 closing price
Ad is loading...

FNWFX vs TEQKX

Header iconFNWFX vs TEQKX Comparison
Open Charts FNWFX vs TEQKXBanner chart's image
American Funds New World F3
Price$82.52
Change-$0.32 (-0.39%)
VolumeN/A
CapitalizationN/A
Nuveen Emerging Markets Eq Idx A
Price$10.96
Change-$0.10 (-0.90%)
VolumeN/A
CapitalizationN/A
FNWFX vs TEQKX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FNWFX vs. TEQKX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNWFX is a Buy and TEQKX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 64.3B vs. TEQKX (7.3B). TEQKX pays higher dividends than FNWFX: TEQKX (2.69) vs FNWFX (1.56). FNWFX was incepted earlier than TEQKX: FNWFX (8 years) vs TEQKX (14 years). FNWFX is a more actively managed with annual turnover of: 32.00 vs. TEQKX (7.00). TEQKX has a lower initial minimum investment than FNWFX: TEQKX (2500) vs FNWFX (1000000). TEQKX (12.24) and FNWFX (12.00) have marching annual gain over last year. FNWFX return over 5 years is better than : 16.03 vs. TEQKX (6.89).
FNWFXTEQKXFNWFX / TEQKX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years14 years-
Gain YTD10.0279.424106%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets64.3B7.3B881%
Annual Yield % from dividends1.562.6958%
Returns for 1 year12.0012.2498%
Returns for 3 years0.71-5.04-14%
Returns for 5 years16.036.89232%
Returns for 10 yearsN/A32.58-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRC75.93-0.76
-0.99%
Brady Corp
GEN29.38-0.35
-1.18%
Gen Digital
SACH1.24-0.03
-2.36%
Sachem Capital Corp
NN17.55-0.45
-2.50%
NextNav
CANF1.42-0.09
-5.96%
Can-Fite BioPharma Ltd